GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human ppargamma ligand binding domain in complex with GW9662 and arachidonic acid

Analyse Crystal structure of human ppargamma ligand binding domain in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6MD2
Type
protein
Length
512 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Peroxisome proliferator-activated receptor gamma
UniProt
P37231
Ligands
GW9, ACD
Pockets
9 · best druggability 0.81

Structure

x-ray diffraction · 2 distinct chains · 68% helix, 5% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APeroxisome proliferator-activated receptor gammaprotein25569% helix, 5% strandP37231
BPeroxisome proliferator-activated receptor gammaprotein25767% helix, 5% strandP37231

Ligands and binding sites

  • GW9 · 2-chloro-5-nitro-N-phenylbenzamide · ligand · 2 copies · chains A, B
  • ACD · Arachidonic acid · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

9 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18290.810.8373GW9, ACD
25230.800.8650GW9, ACD
31380.590.8420empty
41000.570.8619empty
52250.510.7625empty

Interfaces

1 interface between chains.

  • A–B · 928 Ų buried · 9 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 6MD2 · Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with GW9662 and… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.